These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36730891)

  • 1. Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services.
    Schmidt MA; Salas SB; Donald JL; Gift TL; Tao G
    Sex Transm Dis; 2023 May; 50(5):304-309. PubMed ID: 36730891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System.
    Schmidt MA; Dickerson JF; O'Keeffe-Rosetti MC; Salas SB; Donald JL; Tao G
    Sex Transm Dis; 2022 Sep; 49(9):616-621. PubMed ID: 35724111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings.
    Tao G; Pearson WS; Sullivan JM; Henk HJ; Gift TL
    Sex Transm Dis; 2021 Jul; 48(7):515-520. PubMed ID: 33633074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis.
    Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P
    JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany.
    Uhrmacher M; Skaletz-Rorowski A; Nambiar S; Schmidt AJ; Ahaus P; Serova K; Mordhorst I; Kayser A; Wach J; Tiemann C; Münstermann D; Brockmeyer NH; Potthoff A
    Front Public Health; 2022; 10():930208. PubMed ID: 36091531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
    Tang EC; Vittinghoff E; Philip SS; Doblecki-Lewis S; Bacon O; Chege W; Coleman ME; Elion R; Buchbinder S; Kolber MA; Liu AY; Cohen SE
    AIDS; 2020 Jul; 34(8):1181-1186. PubMed ID: 32205724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.
    Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES
    Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment for sexually transmitted infections in men who have sex with men attending a nurse-run HIV preexposure prophylaxis clinic.
    Stockton JM
    J Am Assoc Nurse Pract; 2021 Feb; 33(12):1290-1294. PubMed ID: 33625163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
    Townes A; Tanner MR; Yu L; Johnson WD; Zhu W; Iqbal K; Dominguez KL; Henny KD; Drezner K; Schumacher C; Bickham J; Elopre L; Edelstein ZR; Hoover KW;
    Obstet Gynecol; 2024 Feb; 143(2):294-301. PubMed ID: 37963384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HIV preexposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: a systematic review and meta-analysis.
    Georgiadis N; Papamichail D; Lytras T; Halkitis PN; Tzanakaki G; Kornarou E; Vassilakou NT; Sergentanis TN
    AIDS; 2024 Jun; 38(7):1033-1045. PubMed ID: 38669203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention.
    Newman DR; Rahman MM; Brantley A; Peterman TA
    Clin Infect Dis; 2020 Mar; 70(6):1115-1120. PubMed ID: 30976788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
    de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M;
    HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.